MedTech News
RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
The Accuro 3S Needle Guide Kit, designed for use with the Accuro 3S ultrasound imaging system and Dual-Array transducer, includes single-use, sterile components that support infection control and promote workflow efficiency
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The KPAP sleep therapy platform is developed to offer an adaptive and patient-focused alternative to traditional CPAP therapy
Pulse Biosciences wins FDA IDE to study PFA tech
Pulse Biosciences (Nasdaq:PLSE) announced today that the FDA granted investigational device exemption (IDE) for a pulsed field ablation (PFA) study.
Abbott wins FDA clearance, CE mark for Amplatzer Piccolo delivery system
Abbott (NYSE: ABT)+
announced today that it received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo Occluder.
GlucoModicum unveils Sofio needle-free CGM
GlucoModicum today unveiled Sofio, which it labels the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD).
Medtronic, J&J MedTech both get FDA nods for liquid embolic systems
Medtronic (NYSE: MDT)+
and Johnson & Johnson (NYSE: JNJ)+
have both announced recent regulatory milestones for liquid embolic systems.
3D bioprinting offers alternative to animal testing for skin disease research
At TU Wien, researchers are developing three-dimensional (3D) printing techniques that can be used to create living biological tissue—for example, to study skin diseases.
AI-electrocardiogram model developed to diagnose liver disease earlier
As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease and resulting liver scarring or cirrhosis also are rising. Patients are often diagnosed based on symptoms, such as gastrointestinal bleeding, fluid retention or jaundice, which happen when liver disease has progressed to a late stage.